- Home
- DAWN vs FL Comparison
DAWN vs FL Comparison
Compare DAWN & FL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FL
- Stock Information
- Founded
- DAWN 2018
- FL 1879
- Country
- DAWN United States
- FL United States
- Employees
- DAWN N/A
- FL N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FL Clothing/Shoe/Accessory Stores
- Sector
- DAWN Health Care
- FL Consumer Discretionary
- Exchange
- DAWN Nasdaq
- FL Nasdaq
- Market Cap
- DAWN 658.9M
- FL 2.3B
- IPO Year
- DAWN 2021
- FL N/A
- Fundamental
- Price
- DAWN $7.02
- FL $25.05
- Analyst Decision
- DAWN Strong Buy
- FL Hold
- Analyst Count
- DAWN 7
- FL 15
- Target Price
- DAWN $31.57
- FL $21.00
- AVG Volume (30 Days)
- DAWN 1.3M
- FL 3.6M
- Earning Date
- DAWN 07-29-2025
- FL 08-27-2025
- Dividend Yield
- DAWN N/A
- FL N/A
- EPS Growth
- DAWN N/A
- FL N/A
- EPS
- DAWN N/A
- FL N/A
- Revenue
- DAWN $161,922,000.00
- FL $7,903,000,000.00
- Revenue This Year
- DAWN $17.98
- FL $0.73
- Revenue Next Year
- DAWN $49.50
- FL $2.15
- P/E Ratio
- DAWN N/A
- FL N/A
- Revenue Growth
- DAWN N/A
- FL N/A
- 52 Week Low
- DAWN $6.08
- FL $11.00
- 52 Week High
- DAWN $16.76
- FL $33.94
- Technical
- Relative Strength Index (RSI)
- DAWN 58.34
- FL 72.62
- Support Level
- DAWN $6.52
- FL $24.51
- Resistance Level
- DAWN $7.24
- FL $25.34
- Average True Range (ATR)
- DAWN 0.26
- FL 0.39
- MACD
- DAWN 0.07
- FL -0.15
- Stochastic Oscillator
- DAWN 78.37
- FL 80.67
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About FL Foot Locker Inc.
Foot Locker Inc operates footwear and apparel retailer in North America, Europe, Australia, New Zealand, and Asia, and has licensed store presence in the Middle East, Europe, and Asia. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.